Kinarus Therapeutics

Switzerland
Breíl, Grisons, Switzerland, 4057

Company profile

Kinarus Therapeutics company profile

Kinarus is a biopharmaceutical company that develops differentiated medicines in areas of stress related inflammatory processes based on cross disease area target assessment.

Business identity

Contact email
[email protected]
Phone number
+41 79 865 8969
Operating status
Closed
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2017-09-01

Headquarters

Postal code
4057
Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
6
Total equity funding
$30.2M
Last funding
Post IPO Equity / $1.7M / 2023-05-11
Last equity funding
Post IPO Equity / $1.7M
Investors
2
Lead investors
2
Founders
1
Articles
11
Exited on
2022-06-03

Founders and investors

Founders

Alexander Bausch

Lead investors

Chaodian CultureYorkville Advisors

Investors

Chaodian CultureYorkville Advisors